Exhibits
SC TO-T
from SC TO-T
5 pages
SC TO-T
10/18/22
EX-99.(A)(1)(A)
from SC TO-T
76 pages
OFFER TO PURCHASE FOR CASH Any and All Issued and Outstanding Shares of Common Stock of LOGICBIO THERAPEUTICS, INC. at $2.07 Per Share by CAMELOT MERGER SUB, INC. a Wholly Owned Subsidiary of ALEXION PHARMACEUTICALS, INC
10/18/22
EX-99.(A)(1)(B)
from SC TO-T
10 pages
the Offer and Withdrawal Rights Will Expire at One Minute Following 11:59 P.M. (12:00 Midnight), New York City Time, on Tuesday, November 15, 2022, Unless the Offer Is Extended or Earlier Terminated.
10/18/22
EX-99.(A)(1)(C)
from SC TO-T
4 pages
Exhibit (A)(1)(c)
10/18/22
EX-99.(A)(1)(D)
from SC TO-T
3 pages
To Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
10/18/22
EX-99.(A)(1)(E)
from SC TO-T
4 pages
To Our Clients
10/18/22
EX-99.(A)(1)(F)
from SC TO-T
6 pages
Exhibit (A)(1)(f)
10/18/22
EX-99.(D)(4)
from SC TO-T
12 pages
Confidentiality Agreement
10/18/22
EX-99.(D)(5)
from SC TO-T
6 pages
August 30, 2022 Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston, Massachusetts 02210 Re: Exclusivity Agreement
10/18/22
EX-99.(D)(6)
from SC TO-T
4 pages
Frederic Chereau October 1, 2022 VIA EMAIL
10/18/22
EX-99.(D)(7)
from SC TO-T
4 pages
Mariana Nacht October 1, 2022 VIA EMAIL
10/18/22
EX-99.(D)(8)
from SC TO-T
4 pages
Matthias Hebben October 1, 2022 VIA EMAIL
10/18/22
EX-99.(D)(9)
from SC TO-T
18 pages
Logicbio Therapeutics, Inc. Confidential Information, Invention Assignment, Restricted Activities, and Arbitration Agreement
10/18/22
EX-99.(D)(10)
from SC TO-T
15 pages
Logicbio Therapeutics, Inc. Confidential Information, Invention Assignment, Restricted Activities, and Arbitration Agreement
10/18/22
EX-99.(D)(11)
from SC TO-T
18 pages
Logicbio Therapeutics, Inc. Confidential Information, Invention Assignment, Restricted Activities, and Arbitration Agreement
10/18/22
EX-FILING FEES
from SC TO-T
~5
pages
10/18/22
